Search for: "Novo Nordisk A/S" Results 121 - 140 of 307
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jan 2012, 6:56 pm
Novo Nordisk, the maker of Victoza, has a new Paula Deen website that shows what the required information will include once it trots out Deen in actual ads. [read post]
24 Jan 2012, 10:32 am by Deborah Knapp
According to the New York Post, Nancy Assuncao quit her post as Deen’s publicist last month, citing her distaste for Deen’s deal with Novo Nordisk. [read post]
24 Jan 2012, 10:32 am by Deborah Knapp
According to the New York Post, Nancy Assuncao quit her post as Deen’s publicist last month, citing her distaste for Deen’s deal with Novo Nordisk. [read post]
14 Jun 2013, 6:23 pm
., Novo Nordisk A/S and others, the manufacturers of these drugs may be asked to collect more data on a potential cancer link even as they try to reassure U.S. regulators this week of the drugs’ safety. [read post]
7 Apr 2010, 2:10 am by gmlevine
At least some evidence supporting bad faith is required,” Novo Nordisk A/S v. [read post]
8 Apr 2010, 2:17 am by gmlevine
At least some evidence supporting bad faith is required,” Novo Nordisk A/S v. [read post]
25 Mar 2013, 2:38 pm
Food and Drug Administration, it was reviewing unpublished data by medical researchers which suggest that pre-cancerous cellular changes may be associated with Type 2 diabetes drugs known as incretin mimetics, including Bristol-Myers Squibb’s Byetta and Novo Nordisks Victoza. [read post]
7 Dec 2023, 6:00 am by Levin Papantonio
The JPML issued a Transfer Order to centralize lawsuits alleging that drug manufacturers and pharmacy benefit manufacturers (PBMs) engaged in an unfair and deceptive conspiracy to orchestrate an insulin pricing scheme.Defendants in these actions include insulin manufacturers Eli Lilly and Company, Novo Nordisk, Inc., and Sanofi-Aventis U.S. [read post]
27 Apr 2012, 10:39 am by info@thomasjhenrylaw.com
Novo Nordisk, the drug maker, denies Public Citizen’s allegations and claims that the benefits of Victoza outweigh the risks. [read post]
19 Jun 2017, 12:42 pm by Tom Lamb
The FDA Briefing Materials For A June 2017 Advisory Committee Meeting On Victoza Include A Discussion Of This Safety Issue   (Posted by Tom Lamb at DrugInjuryWatch.com)   On June 20, 2017 there will be an FDA Advisory Committee meeting to discuss Novo Nordisk's supplemental New Drug Application (sNDA) for approval of Victoza® (liraglutide) injection to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial… [read post]
14 Jun 2012, 10:23 am
Victoza is manufactured by Novo Nordisk and was approved by the FDA in January 2010. [read post]
8 Jul 2010, 1:25 pm by FDABlog HPM
Court of Appeals for the Federal Circuit issued its April 2010 decision in Novo Nordisk A/S v. [read post]
13 Dec 2023, 7:11 am by Clay Hodges
After this litigation began, Novo Nordisk (the maker of Ozempic) updated the Ozempic’s label. [read post]
10 Apr 2024, 9:50 am
Novo Nordisk is the only FDA-approved manufacturer of semaglutide. [read post]
21 Oct 2014, 7:20 am
Dynamite in-house faculty speakers – more than 20 of them − including Actavis, Biomet, Bard, GSK, du Pont, Endo, McKesson, Merck, Novo Nordisk, Olympus, Roche, and Teva. [read post]
10 Jun 2022, 11:10 am by Patrick A. Malone
The latest, evolving tangles concern semaglutide and liraglutide, two drugs in a group that experts at the drug maker Novo Nordisk pioneered to treat diabetes. [read post]